Artificial intelligence blood test for early prostate cancer detection
Part of Cancer, Kidney & urinary clinical trials.
This study uses a new artificial intelligence test to look for tiny amounts of cancer DNA in your blood. It aims to help catch prostate cancer earlier, when it may be easier to treat.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male and between 18 and 80 years old.
- Your PSA level is above 4 ng/ml.
- Your doctor has recommended a prostate biopsy because of abnormal PSA, a suspicious exam, or imaging finding.
- You have not had any other cancer in the past 5 years.
- You have not had prostate surgery (like TURP) or prostate cancer treatment before.
- You are not taking blood thinners (or you can stop them for at least a week).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a simple blood test to look for microRNA patterns that may help spot prostate cancer earlier and avoid unnecessary biopsies. If you have elevated PSA or suspicious findings, this test might give more information about your risk.
This study is testing whether artificial intelligence can better predict prostate cancer by combining two types of scans (MRI and PSMA PET) along with your medical history, PSA, and biopsy results. If you have already had these scans and a biopsy, your information may help researchers develop a more accurate, non-invasive diagnostic tool.
This trial uses a special PET scan (PSMA PET) and artificial intelligence to see if we can detect prostate cancer without a needle biopsy. It is for men who are either already scheduled for a PET scan or who have symptoms or high PSA suggesting prostate cancer.
This study tests a new computer program that reads MRI scans to help doctors decide if a prostate biopsy is truly needed. It aims to reduce unnecessary biopsies for men with suspicious test results.
This trial tests a robot-assisted method for taking prostate biopsies using a new type of ultrasound probe. It may help men with certain high-risk features get a more precise diagnosis.
This trial is testing an AI-based early warning system to find prostate and bladder cancer earlier. It is for men over 50 living in Beijing who are willing to take part in the screening and follow-up process.
Hear when a new Benign Prostate Hypertrophy(BPH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.